Hostname: page-component-7c8c6479df-ph5wq Total loading time: 0 Render date: 2024-03-28T11:41:46.282Z Has data issue: false hasContentIssue false

Persistant genital arousal disorder and venlafaxine: A case report

Published online by Cambridge University Press:  13 August 2021

M. Marguilho*
Affiliation:
Clínica 5, Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal
M. Gonçalves
Affiliation:
Clínica 5, Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal
I. Pereira
Affiliation:
Clínica 5, Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal
G. Marinho
Affiliation:
Clínica 5, Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal
A. Nobre
Affiliation:
Clínica 5, Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

In this presentation we describe the case of a woman referred to the Sexology Department after having developed symptoms of Persistent Genital Arousal (PGAD) for the last 5 years, during treatment for Depression with Venlafaxine. PGAD is a clinical entity first described in 2001 by Leiblum and Nathan. Despite having received more attention in the last few years, its etiology remains unclear, with numerous causal factors of different natures being suggested.

Objectives

We aim to describe this clinical case of PGAD and to discuss the possible etiological factors involved as well as to make a brief revision of the literature on this topic.

Methods

We conducted a detailed interview, focused on the nature of the complaints, psychological history, medications, diet and neurologic disorders and performed a thorough clinical examination. We also searched for relevant articles in medical databases such as PubMed and Google Scholar.

Results

A 52 year-old woman previously treated for Depression with Venlafaxine complains of involuntary sensations of genital arousal, with perceived vasocongestion, tingling and pulsatlity during her journey to work in public transportations. The symptoms subsided only after getting home 8-10 hours later and reaching orgasm by masturbating. She stopped Venlafaxine in 2015, but these symptoms persisted. Some authors suggest a link between SSRIs/SNRIs and PGAD.

Conclusions

PGAD is a relatively recent addition to our diagnostic catalog with increasingly more cases being reported in the last few years. It is likely that the condition, however, has no discrete etiology and that a customized approach will be necessary to successfully treat most patients.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.